Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis

Authors: Zhao-Hua Cai, Chun-Lei Fan, Jun-Fu Zheng, Xin Zhang, Wen-Min Zhao, Bing Li, Lei Li, Pei-Ling Dong, Hui-Guo Ding

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

It is difficult to diagnose spontaneous bacterial peritonitis (SBP) early in decompensated liver cirrhotic ascites patients (DCPs). The aim of the study was to measure serum procalcitonin (PCT) levels and peripheral blood leukocyte/platelet (WBC/PLT) ratios to obtain an early diagnostic indication of SBP in DCPs.

Methods

Our cohort of 129 patients included 112 DCPs (94 of whom had infections) and 17 cases with compensated cirrhosis as controls. Bacterial cultures, ascitic fluid (AF) leukocyte and peripheral WBC/PLT counts, and serum PCT measurements at admission were carried out prior to the use of antibiotics. Receiver operating characteristic (ROC) curves were generated to test the accuracies and cut-off values for different inflammatory markers.

Results

Among the 94 infected patients, 66 tested positive by bacterial culture, for which the positivity of blood, ascites and other secretions were 25.8%, 30.3% and 43.9%, respectively. Lung infection, SBP and unknown sites of infection accounted for 8.5%, 64.9% and 26.6% of the cases, respectively. Serum PCT levels (3.02 ± 3.30 ng/mL) in DCPs with infections were significantly higher than those in control patients (0.15 ± 0.08 ng/mL); p < 0.05. We used PCT ≥0.5 ng/mL as a cut-off value to diagnose infections, for which the sensitivity and specificity was 92.5% and 77.1%. The area under the curve (AUC) was 0.89 (95% confidence interval: 0.84–0.91). The sensitivity and specificity were 62.8% and 94.2% for the diagnosis of infections, and were 68.8% and 94.2% for the diagnosis of SBP in DCPs when PCT ≥2 ng/mL was used as a cut-off value. For the combined PCT and WBC/PLT measurements, the sensitivity was 76.8% and 83.6% for the diagnosis of infections or SBP in DCPs, respectively.

Conclusion

Serum PCT levels alone or in combination with WBC/PLT measurements seem to provide a satisfactory early diagnostic biomarker in DCPs with infections, especially for patients with SBP.
Literature
1.
go back to reference Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13–24.CrossRefPubMed Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13–24.CrossRefPubMed
2.
go back to reference Galbois A, Aegerter P, Martel-Samb P, Housset C, Thabut D, Offenstadt G, et al. Improved prognosis of septic shock in patients with cirrhosis: a multicenter study. Crit Care Med. 2014;42:1666–75.CrossRefPubMed Galbois A, Aegerter P, Martel-Samb P, Housset C, Thabut D, Offenstadt G, et al. Improved prognosis of septic shock in patients with cirrhosis: a multicenter study. Crit Care Med. 2014;42:1666–75.CrossRefPubMed
3.
go back to reference Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310–24.CrossRefPubMed Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310–24.CrossRefPubMed
4.
go back to reference Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551–61.CrossRefPubMed Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551–61.CrossRefPubMed
5.
go back to reference Kamani L, Mumtaz K, Ahmed US, Ali AW, Jafri W. Outcomes in culture positive, culture negative ascitic fluid infection in patients with viral cirrhosis: cohort study. BMC Gastroenterol. 2008;8:59.CrossRefPubMedPubMedCentral Kamani L, Mumtaz K, Ahmed US, Ali AW, Jafri W. Outcomes in culture positive, culture negative ascitic fluid infection in patients with viral cirrhosis: cohort study. BMC Gastroenterol. 2008;8:59.CrossRefPubMedPubMedCentral
6.
go back to reference Shalimar, Acharya SK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol. 2013;34:7–13.CrossRefPubMed Shalimar, Acharya SK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol. 2013;34:7–13.CrossRefPubMed
7.
go back to reference Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35:1–10.CrossRefPubMed Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35:1–10.CrossRefPubMed
8.
go back to reference Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed
9.
go back to reference European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef
10.
go back to reference Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patient. BMC Infect Dis. 2013;13:178.CrossRefPubMedPubMedCentral Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patient. BMC Infect Dis. 2013;13:178.CrossRefPubMedPubMedCentral
11.
go back to reference Viallon A, Zeni F, Pouzet V, Lambert C, Quenet S, Aubert G, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med. 2000;26:1082–8.CrossRefPubMed Viallon A, Zeni F, Pouzet V, Lambert C, Quenet S, Aubert G, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med. 2000;26:1082–8.CrossRefPubMed
12.
go back to reference Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;12:9. Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;12:9.
13.
go back to reference Su DH, Zhuo C, Liao K, Cheng WB, Cheng H, Zhao XF. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepato-gastroenterol. 2013;60:641–6. Su DH, Zhuo C, Liao K, Cheng WB, Cheng H, Zhao XF. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepato-gastroenterol. 2013;60:641–6.
14.
go back to reference Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol. 2003;41:165–70.CrossRefPubMed Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol. 2003;41:165–70.CrossRefPubMed
15.
go back to reference Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med. 2011;18:121–6.PubMed Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med. 2011;18:121–6.PubMed
16.
go back to reference Spahr L, Morard I, Hadengue A, Vadas L, Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterol. 2001;48:502–5. Spahr L, Morard I, Hadengue A, Vadas L, Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterol. 2001;48:502–5.
17.
go back to reference Gürol G, Cıftcı IH, Terzi HA, Atasoy AR, Ozbek A, Köroğlu M: Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol 2014, Oct 23. [Epub ahead of print]18. Pleguezuelo M, Benitez JM, Jurado J, Gürol G, Cıftcı IH, Terzi HA, Atasoy AR, Ozbek A, Köroğlu M: Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol 2014, Oct 23. [Epub ahead of print]18. Pleguezuelo M, Benitez JM, Jurado J,
18.
go back to reference Sung-Yeon C, Jung-Hyun C. Biomarkers of sepsis. Infect Chemother. 2014;46:1–12.CrossRef Sung-Yeon C, Jung-Hyun C. Biomarkers of sepsis. Infect Chemother. 2014;46:1–12.CrossRef
20.
go back to reference Lerschmacher O, Koch A, Streetz K, Trautwein C, Tacke F. Management of decompensated liver cirrhosis in the intensive care unit. Med Klin Intensivmed Notfmed. 2013;108:646–56.CrossRefPubMed Lerschmacher O, Koch A, Streetz K, Trautwein C, Tacke F. Management of decompensated liver cirrhosis in the intensive care unit. Med Klin Intensivmed Notfmed. 2013;108:646–56.CrossRefPubMed
21.
go back to reference Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56:S1–S12.CrossRefPubMed Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56:S1–S12.CrossRefPubMed
22.
go back to reference Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology. 2009;50:2022–33.CrossRefPubMed Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology. 2009;50:2022–33.CrossRefPubMed
24.
go back to reference Russwurm S, Wiederhold M, Oberhofer M, Stonans I, Zipfel FP, Reinhart K. Molecular aspects and natural source of procalcitonin. J Clin Chem Lab Med. 1999;37:789–97. Russwurm S, Wiederhold M, Oberhofer M, Stonans I, Zipfel FP, Reinhart K. Molecular aspects and natural source of procalcitonin. J Clin Chem Lab Med. 1999;37:789–97.
25.
go back to reference Mehanic S, Baljic R. The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis. Mater Sociomed. 2013;25:277–81.CrossRefPubMedPubMedCentral Mehanic S, Baljic R. The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis. Mater Sociomed. 2013;25:277–81.CrossRefPubMedPubMedCentral
26.
go back to reference Cekin Y, Cekin AH, Duman A, Yilmaz U, Yesil B, Yolcular BO. The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci. 2013;10:1367–74.CrossRefPubMedPubMedCentral Cekin Y, Cekin AH, Duman A, Yilmaz U, Yesil B, Yolcular BO. The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci. 2013;10:1367–74.CrossRefPubMedPubMedCentral
27.
go back to reference Lazzarotto C, Ronsoni MF, Fayad L, Nogueira CL, Bazzo ML, Narciso-Schiavon JL, et al. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Ann Hepatol. 2013;12:599–607.PubMed Lazzarotto C, Ronsoni MF, Fayad L, Nogueira CL, Bazzo ML, Narciso-Schiavon JL, et al. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Ann Hepatol. 2013;12:599–607.PubMed
Metadata
Title
Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis
Authors
Zhao-Hua Cai
Chun-Lei Fan
Jun-Fu Zheng
Xin Zhang
Wen-Min Zhao
Bing Li
Lei Li
Pei-Ling Dong
Hui-Guo Ding
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0776-4

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue